GNH USA

Europe — EMA

Menopur

GNH USA supplies Menopur (Menotropin), a gonadotropin for infertility due to anovulation, ovarian stimulation in IVF, and male hypogonadotropic hypogonadism.

Menotrophin

Request sourcing

1
Pack/s

What is Menotrophin?

Menotropin, the active ingredient in Menopur, is a gonadotropin presented as an injectable solution for intramuscular or subcutaneous administration. It is used to stimulate ovarian follicular development in women with anovulatory infertility, to support spermatogenesis in men with hypogonadotropic hypogonadism, and for controlled ovarian stimulation in assisted reproductive technology cycles.

GNH USA supplies Menopur as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company follows stringent quality standards and provides cold‑chain logistics for injectable biologics.

What is Menotrophin used for?

Menopur (menotropin) acts on the gonadotropin pathway to treat infertility and related hormonal deficiencies.

Anovulatory infertility: stimulates follicular growth and estradiol production to enable ovulation. Assisted reproductive technology (IVF): provides controlled ovarian hyperstimulation for egg retrieval. Male hypogonadotropic hypogonadism: promotes spermatogenesis by supplying LH and FSH activity.

What are the side effects of Menotrophin?

Menopur may cause a range of adverse reactions, most of which are related to its hormonal activity.

Common Side Effects: - Injection site pain or bruising. - Mild ovarian hyperstimulation syndrome (bloating, abdominal discomfort). - Headache. - Nausea.

Serious or Rare Side Effects: - Severe ovarian hyperstimulation syndrome with rapid weight gain and fluid accumulation. - Thromboembolic events such as deep‑vein thrombosis. - Allergic reactions, including anaphylaxis. - Multiple pregnancy (twins, triplets, etc.).

What precautions apply to Menotrophin?

Before initiating Menopur, clinicians should consider several safety measures.

Dose individualization: adjust based on ovarian response and hormone monitoring. Monitor estradiol levels: avoid excessive stimulation. Avoid use in uncontrolled thyroid disease. Use caution in patients with ovarian cysts. Pregnancy testing: ensure patient is not pregnant before starting. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Menotrophin interact with?

Menopur can interact with other hormonal and systemic agents.

Major Interactions (Avoid): - GnRH antagonists: may blunt response to Menopur. - Oral contraceptives: suppress endogenous gonadotropins, reducing efficacy. - Corticosteroids: may increase risk of ovarian hyperstimulation.

Moderate Interactions (Monitor Closely): - Thyroid hormone replacement: adjust dosing based on thyroid status. - Anticoagulants: monitor for thrombotic risk during ovarian hyperstimulation. - Diuretics: may mask fluid shifts associated with hyperstimulation.

Frequently asked questions

What is Menopur used for?+
Menopur is a gonadotropin preparation used to treat infertility. In women it stimulates ovarian follicular development for anovulatory infertility and for controlled ovarian stimulation in assisted reproductive technology cycles. In men it provides LH and FSH activity to support spermatogenesis in cases of hypogonadotropic hypogonadism.
How does Menotropin work?+
Menotropin contains both follicle‑stimulating hormone (FSH) and luteinizing hormone (LH) activity. The hormones bind to their respective receptors on ovarian granulosa cells and testicular Leydig cells, activating adenylate cyclase and raising intracellular cAMP. This triggers follicle growth and estradiol production in women and testosterone synthesis that drives sperm production in men.
What is the usual dose of Menopur?+
The dose of Menopur is individualized by the prescribing physician based on the patient’s hormonal profile, ovarian response, and treatment goals. Clinicians typically start with a low dose and adjust according to serial ultrasound and estradiol measurements, following established fertility clinic protocols.
Is Menopur safe in pregnancy or breastfeeding?+
Menopur is not intended for use during an established pregnancy and should be discontinued once pregnancy is confirmed. Safety data for breastfeeding are limited; therefore, the medication is generally avoided while nursing. Patients should discuss any concerns with their healthcare provider.
How do I order Menopur from GNH USA?+
To order Menopur, submit an enquiry on the product page at gnh-usa.com indicating the required quantity. GNH USA supplies hospitals, pharmacies and procurement teams worldwide. After the request, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details (including cold‑chain handling) and any necessary import documentation.
How does Menopur compare with the main alternative drug or class?+
The primary alternative to Menopur is recombinant FSH (e.g., follitropin alfa). Both provide FSH activity, but Menopur also contains LH activity, which can be advantageous for patients who need combined gonadotropin support. Recombinant products are highly purified and have a consistent batch‑to‑batch profile, while Menopur is derived from urinary sources and may be more cost‑effective in some markets.
What are the storage and handling requirements for Menopur?+
Menopur must be stored refrigerated at 2‑8 °C. Keep the vial in its original packaging, protect it from light, and do not freeze or shake the solution. If a short‑term excursion above 8 °C occurs, the product should be used within 24 hours provided it remains visually clear and free of particles.
How is Menopur administered?+
Menopur is supplied as a sterile injectable solution. After reconstitution according to the package insert, it is administered by a trained professional via intramuscular or subcutaneous injection. The injection site is typically the abdomen or thigh, and dosing intervals are determined by the treating physician based on monitoring results.
What are the most serious risks to watch for while using Menopur?+
The most serious risks include severe ovarian hyperstimulation syndrome (OHSS), which can cause rapid weight gain, abdominal distension, and electrolyte imbalance, and thromboembolic events such as deep‑vein thrombosis. Rarely, anaphylactic reactions may occur. Patients should be educated to seek immediate medical attention if they experience severe abdominal pain, shortness of breath, or signs of an allergic reaction.
Who should not use Menopur?+
Menopur is contraindicated in women who are already pregnant, have uncontrolled thyroid disease, active ovarian cysts, or a known hypersensitivity to menotropin or any excipients. Men with severe pituitary disorders that are not correctable, or those with a history of thromboembolic disease, should also avoid using this medication unless specifically directed by a specialist.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Menotrophin
Route
Intramuscular Use , Subcutaneous Use
Manufacturer
Ferring Gmbh
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU